Polypharmacy Risk Reduction in the Context of Complexity, Frail and End of Life
Polypharmacy Risk Reduction in the Context of Complexity, Frail and …
Polypharmacy Risk Reduction in the Context of Complexity, Frail and End of Life See Resource »
Polypharmacy Risk Reduction in the Context of Complexity, Frail and …
Polypharmacy Risk Reduction in the Context of Complexity, Frail and End of Life See Resource »
(Dr. Ted Rosenberg, 2015)
(Dr. Chris Rauscher, 2017)